Skip to main content
. 2021 Sep 21;17(14):3936–3953. doi: 10.7150/ijbs.63732

Table 3.

Morphological and biochemical changes in mice with different Lrp6 genotypes under different treatments

Parameters Lrp6(+/+) genotype Lrp6(+/-) genotype
MCS MCD MCD+Silibinin MCS MCD MCD+Silibinin
Liver body ratio (%) 3.87±0.16 5.71±0.76*** 4.62±0.69# 3.91±0.19 5.28±0.32*** 4.70±0.54
ALT (U/L) 28.25±4.99 411.57±59.30*** 306.43±27.82# 37.70±19.85 323.58±43.15*** 272.36±16.73#
AST (U/L) 124.35±44.45 466.68±81.96*** 342.23±43.18# 150.05±19.87 308.15±32.93*** 253.98±36.43
LDL (mmol/L) 0.60±0.05 0.12±0.03*** 0.17±0.02# 0.50±0.13 0.17±0.03*** 0.19±0.03
MDA (μmol/g protein) 0.52±0.11 1.96±0.20*** 1.22±0.57 0.48±0.04 1.43±0.14*** 1.19±0.19
TG (mmol/g protein) 0.21±0.05 0.34±0.03*** 0.27±0.06 0.22±0.05 0.33±0.06* 0.29±0.02
TC (mmol/g protein) 27.28±8.48 55.54±3.04*** 35.09±18.11 22.80±10.34 42.03±2.78** 34.73±3.36

Note: MCS, the mice were fed with methionine- and cystine supplement diet; MCD, the mice were fed with methionine-choline deficient diet; MCD+Silibinin, the mice were coadministrated with 100mg/kg/d silibinin by intragastric during MCD feed;

Abbreviations: ALT, alanine transaminase; AST, aspartate aminotransferase; LDL, low-density lipoprotein; MDA, malondialdehyde; TG, triglyceride; TC, total cholesterol.

* P<0.05; ** P<0.01; ** P<0.001; Statistic analysis were performed between MCS and MCD groups.

# P<0.05; Statistic analysis were performed between MCD and MCD+Silibinin groups.